Literature DB >> 27335628

A prospective and retrospective analysis of smoking behavior changes in ever smokers with high risk for lung cancer from New Mexico and Pennsylvania.

Shuguang Leng1, Joel L Weissfeld2, Maria A Picchi1, Mindi A Styn3, Eric D Claus4, Vincent P Clark4, Guodong Wu1, Cynthia L Thomas1, Frank D Gilliland5, Jianmin Yuan6, Jill M Siegfried7, Steven A Belinsky1.   

Abstract

Cigarette smoking is the leading preventable cause of death worldwide. The aim of this study is to conduct a prospective and retrospective analysis of smoking behavior changes in the Lovelace Smokers Cohort (LSC) and the Pittsburgh Lung Screening Study cohort (PLuSS). Area under the curve (AUC) for risk models predicting relapse based on demographic, smoking, and relevant clinical variables was 0.93 and 0.79 in LSC and PLuSS, respectively. The models for making a quit attempt had limited prediction ability in both cohorts (AUC≤0.62). We identified an ethnic disparity in adverse smoking behavior change that Hispanic smokers were less likely to make a quit attempt and were more likely to relapse after a quit attempt compared to non-Hispanic Whites. SNPs at 15q25 and 11p14 loci were associated with risk for smoking relapse in the LSC. Rs6495308 at 15q25 has a large difference in minor allele frequency between non-Hispanic Whites and Hispanics (0.46 versus 0.23, P<0.0001) and was associated with risk for ever relapse at same magnitude between the two ethnic groups (OR=1.36, 95% CI=1.10 to 1.67 versus 1.59, 95% CI=1.00 to 2.53, P=0.81). In summary, the risk prediction model established in LSC and PLuSS provided an excellent to outstanding distinguishing for abstainers who will or will not relapse. The ethnic disparity in adverse smoking behavior between Hispanics and non-Hispanic Whites may be at least partially explained by the sequence variants at 15q25 locus that contains multiple nicotine acetylcholine receptors.

Entities:  

Keywords:  Smoking behavior; ethnicity; risk prediction model; single nucleotide polymorphism

Year:  2016        PMID: 27335628      PMCID: PMC4913225     

Source DB:  PubMed          Journal:  Int J Mol Epidemiol Genet        ISSN: 1948-1756


  21 in total

1.  Biochemical verification of tobacco use and cessation.

Authors: 
Journal:  Nicotine Tob Res       Date:  2002-05       Impact factor: 4.244

2.  Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening.

Authors:  Cynthia O Townsend; Matthew M Clark; James R Jett; Christi A Patten; Darrell R Schroeder; Liza M Nirelli; Stephen J Swensen; Richard D Hurt
Journal:  Cancer       Date:  2005-05-15       Impact factor: 6.860

3.  Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST).

Authors:  H Ashraf; P Tønnesen; J Holst Pedersen; A Dirksen; H Thorsen; M Døssing
Journal:  Thorax       Date:  2008-12-03       Impact factor: 9.139

4.  Duration of smoking abstinence and success in quitting.

Authors:  E A Gilpin; J P Pierce; A J Farkas
Journal:  J Natl Cancer Inst       Date:  1997-04-16       Impact factor: 13.506

5.  Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.

Authors:  Caryn Lerman; Robert A Schnoll; Larry W Hawk; Paul Cinciripini; Tony P George; E Paul Wileyto; Gary E Swan; Neal L Benowitz; Daniel F Heitjan; Rachel F Tyndale
Journal:  Lancet Respir Med       Date:  2015-01-12       Impact factor: 30.700

6.  15q12 variants, sputum gene promoter hypermethylation, and lung cancer risk: a GWAS in smokers.

Authors:  Shuguang Leng; Yushi Liu; Joel L Weissfeld; Cynthia L Thomas; Younghun Han; Maria A Picchi; Christopher K Edlund; Randall P Willink; Autumn L Gaither Davis; Kieu C Do; Tomoko Nukui; Xiequn Zhang; Elizabeth A Burki; David Van Den Berg; Marjorie Romkes; W James Gauderman; Richard E Crowell; Yohannes Tesfaigzi; Christine A Stidley; Christopher I Amos; Jill M Siegfried; Frank D Gilliland; Steven A Belinsky
Journal:  J Natl Cancer Inst       Date:  2015-02-23       Impact factor: 13.506

7.  Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior.

Authors:  Thorgeir E Thorgeirsson; Daniel F Gudbjartsson; Ida Surakka; Jacqueline M Vink; Najaf Amin; Frank Geller; Patrick Sulem; Thorunn Rafnar; Tõnu Esko; Stefan Walter; Christian Gieger; Rajesh Rawal; Massimo Mangino; Inga Prokopenko; Reedik Mägi; Kaisu Keskitalo; Iris H Gudjonsdottir; Solveig Gretarsdottir; Hreinn Stefansson; John R Thompson; Yurii S Aulchenko; Mari Nelis; Katja K Aben; Martin den Heijer; Asger Dirksen; Haseem Ashraf; Nicole Soranzo; Ana M Valdes; Claire Steves; André G Uitterlinden; Albert Hofman; Anke Tönjes; Peter Kovacs; Jouke Jan Hottenga; Gonneke Willemsen; Nicole Vogelzangs; Angela Döring; Norbert Dahmen; Barbara Nitz; Michele L Pergadia; Berta Saez; Veronica De Diego; Victoria Lezcano; Maria D Garcia-Prats; Samuli Ripatti; Markus Perola; Johannes Kettunen; Anna-Liisa Hartikainen; Anneli Pouta; Jaana Laitinen; Matti Isohanni; Shen Huei-Yi; Maxine Allen; Maria Krestyaninova; Alistair S Hall; Gregory T Jones; Andre M van Rij; Thomas Mueller; Benjamin Dieplinger; Meinhard Haltmayer; Steinn Jonsson; Stefan E Matthiasson; Hogni Oskarsson; Thorarinn Tyrfingsson; Lambertus A Kiemeney; Jose I Mayordomo; Jes S Lindholt; Jesper Holst Pedersen; Wilbur A Franklin; Holly Wolf; Grant W Montgomery; Andrew C Heath; Nicholas G Martin; Pamela A F Madden; Ina Giegling; Dan Rujescu; Marjo-Riitta Järvelin; Veikko Salomaa; Michael Stumvoll; Tim D Spector; H-Erich Wichmann; Andres Metspalu; Nilesh J Samani; Brenda W Penninx; Ben A Oostra; Dorret I Boomsma; Henning Tiemeier; Cornelia M van Duijn; Jaakko Kaprio; Jeffrey R Gulcher; Mark I McCarthy; Leena Peltonen; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2010-04-25       Impact factor: 38.330

8.  Genome-wide meta-analyses identify multiple loci associated with smoking behavior.

Authors: 
Journal:  Nat Genet       Date:  2010-04-25       Impact factor: 38.330

Review 9.  Smoking cessation in patients with respiratory disease: existing treatments and future directions.

Authors:  Nancy A Rigotti
Journal:  Lancet Respir Med       Date:  2013-05-03       Impact factor: 30.700

10.  A genomewide association study of smoking relapse in four European population-based samples.

Authors:  Federica Tozzi; Alexander Teumer; Marcus Munafò; Rajesh Rawal; Gbenga Kazeem; Marcel Gerbaulet; Wendy McArdle; Howard Chilcoat; Angela Döring; Norbert Dahmen; Vincent Mooser; Matthias Nauck; Susan M Ring; Justin P Rubio; Peter Vollenweider; Gérard Waeber; Ulrich John; Henry Völzke; Georg Homuth; Harald J Freyberger; Uwe Völker; George Davey-Smith; Christian Gieger; Martin Preisig; Hans J Grabe
Journal:  Psychiatr Genet       Date:  2013-08       Impact factor: 2.458

View more
  1 in total

1.  New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease.

Authors:  Qinjie Weng; Qiongxiu Zhou; Jun Tong; Yuanmeng Jin; Yunzi Liu; Xialian Yu; Xiaoxia Pan; Hong Ren; Weiming Wang; Jingyuan Xie; Nan Chen
Journal:  Clin Proteomics       Date:  2020-05-29       Impact factor: 3.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.